Indian manufacturing companies saw sales jump 14.5 percent in early 2026. Automobiles, electrical machinery, and metals led this growth. Ov...

HCL Tech share price gained 3% after i invested $150 million in Sarvam AI, India's largest AI startup, acquiring a 10.46% stake. This strat...

Brigade Enterprises in May announced its first bonus issue in around seven years, along with the release of its Q4 results. It said its boa...

BenQ is integrating on-device generative AI into Indian classrooms with its new RP05 interactive display, simplifying teaching tasks. Beyon...

Ernest Hemingway, a Nobel Prize-winning author, emphasized the profound value of patient listening for learning and personal growth. He urg...

Amidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...

Olivia Rodrigo has shared a personal health detail. She lives with partial deafness in her left ear. This condition has been with her since...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Helios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...

Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

Peter McGuire of Australia-Trading.com highlights a chaotic market driven by rumors and geopolitics, not fundamentals. He predicts crude oi...

What is Planet Nine, and where is it? The question has fascinated astronomers for years. Scientists believe a massive undiscovered planet m...

BofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...

The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...

Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...